Health Desk-- 31 July, 2018: Japanese researchers on Monday announced the first human trial using a kind of stem cell to treat Parkinson’s disease, building on earlier animal trials.
According to a press release, the research team at Kyoto University plans to inject five million induced Pluripotent Stem (iPS) cells — which have the potential to develop into any cell in the body — into patient brains.
The iPS cells from healthy donors will be developed into dopamine- producing brain cells, which are no longer present in people with Parkinson’s disease.
Parkinson’s disease is a chronic, degenerative neurological disorder that affects the body’s motor system, often causing shaking and other difficulties in movement.
According to the Parkinson’s Disease Foundation, about 10 million people have the illness across the globe.
The foundation says currently available therapies “improve symptoms without slowing or halting the disease progression,”. But the new research aims to actively reverse the disease.
The clinical test with seven participants aged between 50 and 69 will begin on Wednesday.